Bicocca Open Archive

Logo unimib boa
MEREGALLI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.630
EU - Europa 6.710
AS - Asia 4.262
SA - Sud America 245
AF - Africa 45
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 18
Totale 21.941
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.420
SG - Singapore 1.841
IT - Italia 1.319
RU - Federazione Russa 1.186
DE - Germania 1.144
CN - Cina 1.063
SE - Svezia 865
IE - Irlanda 706
HK - Hong Kong 498
UA - Ucraina 483
GB - Regno Unito 302
BR - Brasile 205
CA - Canada 194
ID - Indonesia 164
VN - Vietnam 152
FI - Finlandia 141
AT - Austria 135
FR - Francia 125
IN - India 119
KR - Corea 105
DK - Danimarca 85
JP - Giappone 84
TR - Turchia 77
NL - Olanda 67
BE - Belgio 48
IR - Iran 38
TW - Taiwan 32
PL - Polonia 25
ZA - Sudafrica 19
EU - Europa 18
AU - Australia 17
ES - Italia 17
EG - Egitto 14
NZ - Nuova Zelanda 14
IL - Israele 13
EC - Ecuador 10
MX - Messico 10
CH - Svizzera 9
IQ - Iraq 8
PK - Pakistan 8
BD - Bangladesh 7
BG - Bulgaria 7
PE - Perù 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
KZ - Kazakistan 6
GR - Grecia 5
MA - Marocco 5
PH - Filippine 5
PT - Portogallo 5
PY - Paraguay 5
CZ - Repubblica Ceca 4
JO - Giordania 4
KG - Kirghizistan 4
RS - Serbia 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
VE - Venezuela 4
CO - Colombia 3
EE - Estonia 3
HR - Croazia 3
LV - Lettonia 3
MD - Moldavia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CL - Cile 2
GT - Guatemala 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
NG - Nigeria 2
OM - Oman 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
TN - Tunisia 1
UY - Uruguay 1
Totale 21.941
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.831
Singapore 1.216
Dublin 684
Chandler 666
Woodbridge 649
Frankfurt am Main 631
Milan 532
Wilmington 532
Jacksonville 458
Dearborn 453
Hong Kong 448
Houston 413
Fairfield 405
Ashburn 388
New York 312
Santa Clara 305
Princeton 271
Nanjing 196
Seattle 177
Boardman 165
Jakarta 149
Shanghai 139
Cambridge 125
Vienna 115
Beijing 86
Dong Ket 74
Lachine 74
Guangzhou 72
Lawrence 67
Nanchang 67
Altamura 61
Council Bluffs 56
Shenyang 54
Helsinki 53
Moscow 51
Andover 49
Los Angeles 49
Nuremberg 46
Fremont 43
Jinan 41
Toronto 40
Chicago 39
Brussels 37
Pune 36
Melzo 35
Rome 35
Ottawa 34
San Diego 34
Falls Church 32
Tianjin 31
Hangzhou 30
Zhengzhou 28
Daejeon 26
London 26
Carate Brianza 25
Changsha 25
Jiaxing 25
Kunming 25
Tokyo 25
Nürnberg 23
Grafing 21
Norwalk 21
Sacramento 21
Hebei 20
Shangdi 20
Bergamo 19
Dallas 19
San Antonio 18
Seoul 18
Mountain View 17
Edmonton 16
Munich 16
São Paulo 16
Hägersten 15
Kocaeli 15
Leawood 15
Ningbo 15
Hefei 14
Kiev 14
Lissone 14
Phoenix 13
Washington 13
Baltimore 12
Codroipo 12
Düsseldorf 12
Kaohsiung 12
Shinjuku 12
Cagliari 11
Kraków 11
Norristown 11
Ankara 10
Belo Horizonte 10
Florence 10
Lappeenranta 10
Taizhou 10
Buffalo 9
Canazei 9
Istanbul 9
Mainz 9
Monza 9
Totale 14.372
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 335
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 313
Age-related changes in the function and structure of the peripheral sensory pathway in mice 308
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 308
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 307
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 265
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 253
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 253
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 245
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 240
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 234
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 234
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 231
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 230
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 224
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 224
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 220
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 220
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 214
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 214
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 209
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 209
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 208
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 207
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 199
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 196
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 194
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 194
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 192
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 192
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 190
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 190
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 189
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 188
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 186
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 182
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 182
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 179
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 177
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 174
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 172
Role of ER-mitochondria interaction in the mechanism of chemotherapy-induced peripheral neuropathy 169
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 167
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 165
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 165
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 165
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 164
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 162
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 160
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 159
Granulocytes in actively induced Lewis rat EAE 156
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 156
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 155
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 154
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 149
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 148
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 147
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 146
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 146
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 146
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 144
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 143
Multimodal experimental approach to the study of human neurological diseases 143
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 143
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 143
MSCs effect on Dark Agouti rats affected by chronic EAE 142
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 142
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 142
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 142
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 142
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 140
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 140
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 138
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 138
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 138
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 137
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 136
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 136
CIPN and its mechanism of development 135
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 135
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 134
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 133
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 132
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 132
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 131
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 129
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 127
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 127
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 126
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 125
Characterization of proteasome inhibition and tubulin stabilization in an in vivo rat model of bortezomib-induced peripheral neuropathy 124
Methylene blue protects against paclitaxel-induced peripheral neurotoxicity 124
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 123
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 122
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 122
Pharmacokinetics of IVIg in Wistar rats 118
Neurotoxicity induced by cisplatin, taxol and bortezomib in immunocompetent cd1 mice and immunodeficient nude mice 117
Caratterizzazione dell'effetto analgesico di un nuovo ligando del recettore I2 imidazolinico in un modello animale di dolore neuropatico indotto da bortezomib 116
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 116
Clinical and preclinical features of eribulin-related peripheral neuropathy 116
Totale 17.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020495 0 0 0 0 0 0 0 0 0 254 199 42
2020/20213.099 128 88 317 297 247 275 334 313 292 261 220 327
2021/20221.905 161 214 167 180 142 174 84 99 67 121 143 353
2022/20232.991 376 737 335 270 222 486 42 144 223 43 76 37
2023/20242.539 83 65 69 89 329 590 408 114 148 53 45 546
2024/20256.141 422 859 661 432 651 380 511 283 935 1.007 0 0
Totale 23.274